Pervasive transcription is widespread amongst eukaryotic genomes, and produces long noncoding RNAs (lncRNAs) in addition to classically annotated transcripts such as messenger RNAs (mRNAs). LncRNAs are heterogeneous in length and map to intergenic regions or overlap with annotated genes. Analogous to mRNAs, lncRNAs are transcribed by RNA polymerase II, regulated by common transcription factors, and possess 5’ caps and perhaps 3’ poly(A) tails. However, lncRNAs perform distinct functions, acting as scaffolds for ribonucleoprotein complexes or directing proteins to nucleic acid targets. The act of transcribing a lncRNA can also affect the local chromatin environment. Furthermore, whereas mRNAs are predominantly turned over in the cytoplasm, both nuclear and cytoplasmic pathways reportedly participate in lncRNA degradation. In this study, I address the question of when and how lncRNAs and mRNAs are distinguished in the cell. Messenger RNAs interact with a defined series of protein factors governing their production, processing and decay, and I hypothesised that lncRNAs might be similarly regulated. I therefore sought to determine which mRNA-binding proteins, if any, also bind lncRNAs. I reasoned that this would reveal the point at which lncRNAs and mRNAs diverge, and how differences in their biogenesis and turnover equip them for different roles. I selected factors from key stages of mRNA metabolism in Saccharomyces cerevisiae, and identified their transcriptome-wide targets using CRAC (crosslinking and analysis of cDNAs). CRAC can detect interactions with low abundance transcripts under physiological conditions, and reveal where within each transcript a protein is bound. Analyses of binding sites in mature mRNAs and intron-containing pre-mRNAs revealed the order in which the tested factors interact with mRNAs, and which region they bind. The poly(A)-binding protein Nab2 bound throughout mRNAs, consistent with an architectural role, whereas the cytoplasmic decay factors Xrn1 and Ski2 bound to poly(A) tails, which might act as hubs to coordinate turnover. The RNA packaging factors Tho2 and Gbp2, and nuclear surveillance factors Mtr4 and Trf4 bound abundantly to intron-containing premRNAs, indicating that they act during or shortly after transcription. The tested factors bound lncRNAs to various extents. LncRNA binding was most abundant for Mtr4 and Trf4, moderate for Tho2, Gbp2, the cap binding complex component Sto1, and the 3’ end processing factors Nab2, Hrp1 and Pab1, and lowest for Xrn1, Ski2 and the export receptor Mex67. This suggests that early events in lncRNA and mRNA biogenesis are similar, but unlike mRNAs, most lncRNAs are retained and degraded in the nucleus. Analyses of two documented classes of lncRNA, cryptic unstable transcripts (CUTs) and stable unannotated transcripts (SUTs), revealed some differences. SUTs were most similar to mRNAs, with canonical cleavage and polyadenylation signals flanking their 3’ ends, and poly(A) tails bound by the poly(A)-binding protein Pab1. CUTs lacked these characteristics, and in comparison to SUTs bound more abundantly to Mtr4 and Trf4 and less so to Ski2, Xrn1 and Mex67. Furthermore, CUTs accumulated upon Hrp1 depletion, suggesting that Hrp1 functions non-canonically to promote CUT turnover. Mtr4, Trf4 and Nab2 also bound abundantly to promoter-proximal RNA fragments generated from ~1000 protein coding genes. These fragments possessed short oligo(A) tails (hallmarks of nuclear surveillance substrates), were not bound to cytoplasmic factors, and apparently correspond to a population of ~150-200 nt promoter-proximal lncRNAs. Notably, CRAC analyses of Mtr4 and Sto1 targets in yeast subjected to a media shift revealed widespread changes in the abundance and surveillance of mRNAs, promoter-proximal transcripts and CUTs, which at many loci were arranged in a complex transcriptional architecture. Overall, the transcriptome-wide binding analyses presented here reveal that lncRNAs diverge from mRNAs prior to export, and are predominantly retained in the nucleus. Transcript fate is apparently determined during 3’ end processing, with CUTs diverging from mRNAs early in transcription via a distinct termination pathway coupled to rapid turnover, and SUTs diverging during or shortly after cleavage and polyadenylation, making them more stable and perhaps prone to escape to the cytoplasm. Promoter-proximal transcripts might arise from termination associated with an early checkpoint in Pol II transcription. The diverse behaviours of lncRNAs arise from their association with distinct subsets of RNA binding proteins, some of which perform different roles when bound to different types of transcript. In conclusion, my results provide the foundation for a mechanistic understanding of how distinct classes of non-coding Pol II transcripts are produced, and how they can perform diverse functions throughout the nucleus.

Untersuchungen der Transkriptionsebene individueller präimplantatorischer Embryonalstadien können wertvolle Informationen über den physiologischen Status der betrachteten Embryonen, die z.B. zur Verbesserung der Systeme zur In vitro-Produktion von Embryonen genutzt werden können, liefern. Bisher fehlte es jedoch an einer geeigneten Technologie, um eine große Anzahl von Transkripten in einzelnen Embryonen zu erfassen. Zielsetzung der vorliegenden Arbeit war es, ein Verfahren zur globalen Amplifikation embryonaler mRNA-Präparationen zu entwickeln, das die Analyse der Transkriptionsebene einzelner präimplantatorischer Embryonalstadien über die cDNA-Array-Technologie ermöglicht. Dazu wurde die Strategie gewählt, zwei bereits etablierte Amplifikationsverfahren, Polymerasekettenreaktion und In vitro-Transkription, zu kombinieren, um so synergistische Effekte beider Verfahren zu nutzen. Die Evaluierung des entwickelten Verfahrens zeigte eine hohe Reproduzierbarkeit der erhaltenen Genexpressionsdaten und belegte, dass die relativen Mengenverhältnisse einzelner mRNA-Spezies zueinander während der globalen mRNA-Amplifikation nur unwesentlich verändert wurden. Die entwickelte Methodik ist somit geeignet, komplexe Genexpressionsprofile einzelner Blastozysten zu erstellen und Unterschiede in der Expressionsstärke einzelner Transkripte zu detektieren. Es konnte weiterhin gezeigt werden, dass es möglich ist, über heterologe Hybridisierung Genexpressionsprofile boviner Blastozysten mit cDNA-Arrays, die murine Probensequenzen enthalten, reproduzierbar darzustellen. Neben der Detektion individueller Unterschiede in den Genexpressionsprofilen diverser muriner Embryonalstadien und boviner Blastozysten lag ein Schwerpunkt dieser Arbeit in der Untersuchung der Auswirkungen verschiedener in vitro-Produktionssysteme auf die embryonale Genexpression. Die erhaltenen cDNA-Array Expressionsdaten muriner Oozyten, Zweizeller und Blastozysten befanden sich dabei in Übereinstimmung mit Daten früherer Publikationen anderer Arbeitsgruppen. Genexpressionsprofile in vitro fertilisierter boviner Blastozysten ließen eine Beurteilung der Auswirkungen unterschiedlicher Proteinsupplemente des Kulturmediums auf die embryonale Genexpression zu. Im Rahmen dieser Arbeit wurden zum ersten Mal Genexpressionsprofile einzelner präimplantatorischer Säugerembryonen über cDNA-Array-Analyse erstellt. Die entwickelte Technologie ermöglicht es -bei Verwendung entsprechender cDNA-Array-Systeme-, eine theoretisch unbegrenzte Zahl von Transkripten in individuellen Säugerembryonen semiquantitativ zu erfassen. Dies ist ein wichtiger Schritt hin zu einem besseren Verständnis komplexer Regulationsabläufe während der frühen Embryonalentwicklung und einer besseren Beurteilung der Lebensfähigkeit und Entwicklungskompetenz in vitro produzierter Embryonen, was für die Verbesserung von In vitro-Produktionssystemen für Embryonen sowohl bei Tieren als auch beim Menschen unerlässlich ist. / Transcript expression profiling in single mammalian embryos can provide valuable information about their physiological status and developmental competence that can be exploited to improve systems for embryo in vitro production. Conventional methodologies such as RT-PCR limit the number of transcripts that can be quantitatively screened in a single embryo to only a few. The purpose of this study was to develop and evaluate a methodology for the global amplification of mRNA that permits cDNA-array analysis of individual preimplantation embryos. For this purpose, two conventional amplification procedures – polymerase chain reaction and in vitro transcription – were combined to a global amplification procedure. Evaluation of methodology developed revealed that data produced were high reproducible and that the relative transcript levels found in the original (non-amplified) sample were maintained throughout the amplification process. Thus, this method is suitable to generate complex gene expression profiles and to detect differentially expressed transcripts in individual mammalian embryos. Furthermore, this study demonstrates that expression profiles can reproducibly be produced from bovine embryos using arrays consisting of murine cDNA-probes by heterologous hybridization. The focus of this study was to establish a methodology to detect differentially expressed genes in different murine developmental stages and in bovine embryos derived from different in vitro production systems. The data obtained from murine oocyte, 2-cell stage and blastocyst expression profiles were in agreement with data previously published by other groups. Expression profiles from bovine in vitro fertilized embryos cultured in different media revealed effects of different media protein supplementation on embryonic gene expression. In this study, for the first time, gene expression profiles were generated from single mammalian preimplantation embryos via model cDNA-arrays. Using state-of-the-art cDNA-arrays this technology features the quantitative screening of a virtually unlimited number of transcripts in individual blastocysts and cleavage stages. Complex expression profiles of preimplantation embryos will contribute to the understanding of the molecular mechanisms essential for embryogenesis. This is crucial for the improvement of systems for in vitro production of mammalian embryos.

User interfaces often incorporate sound to notify users of application updates, to enhance games, and to assist complex interactions. Sound exists as a medium that can provide information that humans cannot understand through a purely visual interaction, and in a mobile interface context, using another medium could be useful to mitigate visual limitations in screen space and the amount of users’ attention focused on screen. Smartphones are now a ubiquitous part of people’s lives, and sound interactions can play an important role within these experiences. This study conducts research on users’ interactions with supplemental sounds while using Facebook Messenger. Facebook Messenger is the most popular messaging app in the United States, and its design includes a variety of unique user interface sounds. This study contributes design considerations for both researchers and industry professionals to apply to further research or the application of audio within a mobile messaging space.

INTRODUÇÃO: A relevância da expressão MYCN em neuroblastomas sem amplificação, diferentemente do seu aumento quando amplificado, permanece controverso. Neste trabalho, avaliou-se a relação do nível de expressão do transcrito MYCN em neuroblastoma não amplificado com os fatores clínicos e biológicos de prognóstico. MÉTODOS: Neste estudo observacional realizado entre janeiro de 2000 e dezembro de 2004, foram aferidos os valores do nível de expressão MYCN em 29 amostras tumorais, pela técnica RQ-PCR, no Laboratório de Biologia Tumoral da Fundação Pró-Sangue de São Paulo. Seus resultados foram analisados em relação à idade ao diagnóstico, ao estadiamento tumoral, ao grupo de risco, à ocorrência de recaída tumoral e de óbito. RESULTADOS: Foram nove crianças com idade 1 ano, os valores da expressão do transcrito MYCN variaram de 0,041 e 27,569, mediana 3,193. O estadiamento foi: quatro estádio 1; três estádio 2; oito estádio 3 e 14 crianças estádio 4. Entre 20 crianças com classificação patológica, 11 foram favoráveis e nove desfavoráveis. Considerando a mediana dos valores expressos a estratificação em grupos de risco com aumento da expressão foram: cinco crianças baixo risco; quatro risco intermediário e cinco alto risco. Grupos de risco sem aumento da expressão foram: duas crianças baixo risco; quatro risco intermediário e nove alto risco. Vinte e oito crianças obtiveram remissão completa e entre elas 14 apresentaram doença progressiva, sendo que sete morreram. As variáveis clínicas e biológicas não apresentaram freqüências diferentes entre os grupos de risco sem e com aumento de expressão. Entre os grupo alto risco e não alto-risco as variáveis idade, recaída tumoral e óbito apresentaram resultado com significado estatístico quando não se considerou o valor da expressão e quando não houve o seu aumento. Entre os grupos alto risco e nãoalto risco com aumento da expressão apenas a idade apresentou resultado com significado estatístico. CONCLUSÃO: Em crianças com estádio clínico não avançado o nível de expressão parece exercer uma relevância clínica, sugerindo um efeito protetor quanto menor for o aumento da expressão MYCN. / INTRODUTION: MYCN expression value in non-amplified neuroblastosmas remains a controversial issue. In order to add contributions to this field, children with nonamplified neuroblastomas were studied regarding their expression and correlation with clinical and other biological factors. METHODS: Twenty nine tumor samples obtained from non-consecutive patients admitted from January, 2000 through December, 2004, had their MYCN transcript expression levels evaluated according to the RQ-PCR assay, at the Tumoral Biology of Laboratory of the \"Fundação Pró -Sangue Hemocentro de São Paulo\", and compared to the following other factor: age at onset; tumor stage; risk - group; tumoral relapse rate and death. RESULTS: nine under one-year-old children and 20 over one-year-old children, with MYCN transcription expression level between 0.041 and 27.569, mean 3.193. Four children were stage 1, three were stage 2, stage 3 in eight and stage 4 in 14 children. In 20 patients with pathological classifications, 11 were favorable and nine unfavorable histology. Children whose expression level was above the mean were stratified as follows according to risk groups: five low-risk; four intermediate-risk and five high-risk patients. The ones whose expression level was under the mean were two low-risk, four intermediate-risk end nine high-risk patients. Twenty eight children achieved complete remission, with 14 recurrences, with seven deaths. The only factor associated to highly expressed MYCN patients was tumoral state. CONCLUSION: In children with non-advanced-stage disease low levels of expression might be a relevant favorable prognostic factor.

Chan Kam Leung. / Thesis (M.Phil.)--Chinese University of Hong Kong, 1999. / Includes bibliographical references (leaves 175-182). / Abstract also in Chinese. / Acknowledgements --- p.i / Abstract --- p.ii / Abbreviations --- p.v / Table of Contents --- p.vii / Chapter Chapter 1 --- General Introduction / Chapter 1.1 --- Drosophila as a model for studying development --- p.1 / Chapter 1.2 --- The formation of the body axis in Drosophila --- p.2 / Chapter 1.3 --- The maternal genes are essential for development --- p.9 / Chapter 1.4 --- Maternal gene bicoid is essential for formation of the anterior structures in the embryo --- p.11 / Chapter 1.5 --- The formation of the biocid protein gradient from anterior pole to posterior pole of the embryo --- p.13 / Chapter 1.6 --- The bed protein gradient controls the downstream zygotic target genes in a concentration-dependent manner --- p.15 / Chapter 1.7 --- The formation of the bed protein gradient in embryo --- p.17 / Chapter 1.8 --- Components required for bcd mRNA localization at anterior pole of oocyte --- p.21 / Chapter 1.8.1 --- Cis-acting elements --- p.21 / Chapter 1.8.2 --- Trans-acting elements --- p.21 / Chapter 1.9 --- The properties of exuperantia protein --- p.25 / Chapter 1.9.1 --- The function of exu protein --- p.25 / Chapter 1.9.2 --- Exuperantia is a phosphoprotein --- p.26 / Chapter 1.9.3 --- Phosphorylation pattern of exuperantia protein is stage-specific --- p.28 / Chapter 1.9.4 --- Reversible phosphorylation is one of the major mechanisms to control protein activity in all eukaryotic cells --- p.29 / Chapter 1.9.5 --- The relationship between the exu protein phosphorylation and the bcd mRNA localization --- p.30 / Chapter 1.10 --- Aim of project --- p.31 / Chapter CHAPTER 2 --- Preparation of the exuperantia genomic DNA and complement DNA (cDNA) mutant Constructs / Chapter 2.1 --- Introduction --- p.33 / Chapter 2.2 --- Materials and methods --- p.35 / Chapter 2.2.1 --- DNA preparation methods --- p.35 / Chapter 2.2.1.1 --- Preparation of double-stranded DNA by polyethylene glycol6000 --- p.35 / Chapter 2.2.1.2 --- Preparation of M13mp8 single-stranded DNA --- p.37 / Chapter 2.2.1.3 --- "Preparation of double-stranded DNA by Biol prep (Modified from Maniatis et al.,1989)" --- p.38 / Chapter 2.2.2 --- "Preparation of DH5α，JM109, TG1 competent cells" --- p.39 / Chapter 2.2.3 --- Bacteria transformation --- p.40 / Chapter 2.2.4 --- Restriction enzyme digestion --- p.40 / Chapter 2.2.5 --- Phenol/chloroform extraction --- p.41 / Chapter 2.2.6 --- Purification of DNA fragment by electro-elution --- p.42 / Chapter 2.2.7 --- DNA ligation --- p.43 / Chapter 2.2.8 --- DNA dephosphorylation --- p.43 / Chapter 2.2.9 --- In vitro site-directed mutagenesis --- p.44 / Chapter 2.2.9.1 --- The Sculptor´ёØ in vitro mutagenesis --- p.44 / Chapter 2.2.9.2 --- The GeneEditor´ёØ in vitro site-directed mutagenesis --- p.47 / Chapter 2.2.10 --- The double-stranded or single-stranded DNA sequencing by T7 DNA polymerase sequencing system --- p.50 / Chapter 2.2.11 --- Denatured polyacrylamide gel electorphoresis --- p.51 / Chapter 2.2.11 --- Nucleotide sequence of the sequencing primers and the mutageneic oligonucleotides --- p.54 / Chapter 2.3 --- Results --- p.55 / Chapter 2.3.1 --- Design exuperantia mutant constructs --- p.55 / Chapter 2.3.1.1 --- Comparison of exu protein amino acids sequence with different Drosophila species --- p.56 / Chapter 2.3.2 --- The exu genomic mutant constructs --- p.63 / Chapter 2.3.3 --- The exu cDNA mutant constructs --- p.63 / Chapter 2.4 --- Discussion --- p.76 / Chapter CHAPTER 3 --- Epitope tagging of exuperantia protein with c-myc eptiope / Chapter 3.1 --- Introduction --- p.79 / Chapter 3.2 --- Materials and methods --- p.84 / Chapter 3.2.1 --- Preparation of the c-myc eptiope DNA fragment --- p.84 / Chapter 3.2.2 --- End-filling of 5'overhang DNA fragment by Klenow fragment --- p.86 / Chapter 3.2.3 --- In vitro translation of protein by TNT® Quick coupled transcription and translation system --- p.86 / Chapter 3.2.4 --- Immunoprecipitation of recombinant exu protein --- p.87 / Chapter 3.2.5 --- Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) --- p.88 / Chapter 3.2.5.1 --- SDS-PAGE preparation --- p.88 / Chapter 3.2.5.2 --- SDS-PAGE electrophoresis --- p.90 / Chapter 3.2.6 --- Western blot analysis --- p.90 / Chapter 3.2.6.1 --- Transfer the protein to a nitro-cellulose membrane by semi-dried blotting --- p.90 / Chapter 3.2.6.2 --- Western blot blocking and antibody recognition --- p.91 / Chapter 3.3 --- Results --- p.92 / Chapter 3.3.1 --- Construction of the plasmid containing exu cDNA tagging with a c-myc epitope --- p.92 / Chapter 3.3.2 --- In vitro translation of c-myc epitope tagged exu protein --- p.102 / Chapter 3.3.3 --- Immunoprecipitation of c-myc labeled exu protein by a polyclonal rabbit anti-exu antibody and monoclonal mouse anti-myc antibody --- p.104 / Chapter 3.4 --- Discussion --- p.109 / Chapter CHAPTER 4 --- In vitro phosphorylation of exuperantia Protein / Chapter 4.1 --- Introduction --- p.111 / Chapter 4.2 --- Materials and methods --- p.113 / Chapter 4.2.1 --- Exogenous kinase phsophorylation reactions --- p.113 / Chapter 4.2.2 --- Separation of the phosphorylated exu protein variants by SDS- PAGE --- p.114 / Chapter 4.3 --- Results --- p.115 / Chapter 4.3.1 --- Western blot analysis of in vitro translated exu protein variants --- p.115 / Chapter 4.3.2 --- Phosphorylation of in vitro translated exu protein variants by exogenous cAMP-dependent protein kinase --- p.118 / Chapter 4.3.3 --- Phosphorylation of in vitro translated exu protein variants by exogenous cGMP-dependent protein kinase --- p.123 / Chapter 4.3.4 --- Phosphorylation of in vitro translated exu protein variants by exogenous protein kinase C --- p.128 / Chapter 4.4 --- Discussion --- p.133 / Chapter CHAPTER 5 --- Introduction of the exuperantia genomic constrcuts into the germline of Drosophila by P element-mediated transformation / Chapter 5.1 --- Introduction --- p.136 / Chapter 5.2 --- Materials and methods --- p.138 / Chapter 5.2.1 --- Construction of a genomic construct for production of transgenic flies --- p.138 / Chapter 5.2.2 --- Preparation of double-stranded DNA by ultra-centrifugation --- p.142 / Chapter 5.2.3 --- P-element mediated transformation --- p.143 / Chapter 5.2.3.1 --- Eggs collection --- p.143 / Chapter 5.2.3.2 --- Dechorionating the eggs --- p.143 / Chapter 5.2.3.3 --- Orientating the eggs --- p.144 / Chapter 5.2.3.4 --- Microinjection --- p.145 / Chapter 5.2.4 --- Collecting virgin female Drosophila --- p.146 / Chapter 5.2.5 --- Setup a crossing experiment --- p.146 / Chapter 5.2.6 --- Preparation of total ovaries and testes extracts exu protein from Female and male Drosophila --- p.147 / Chapter 5.2.7 --- Immunohistochemical distribution of exuperantia protein --- p.147 / Chapter 5.3 --- Results --- p.150 / Chapter 5.3.1 --- Insertion of the mutated exu fragments into the Drosophila Transformation vector (pCaSpeR) --- p.150 / Chapter 5.3.2 --- Introduction of the mutated exu gene into the genome of Drosophila by P-element mediated transformation --- p.153 / Chapter 5.3.3 --- Western blot analysis of the exu protein in the exu (ES2.1) transgenic fly --- p.160 / Chapter 5.3.4 --- Immunohistochemical distribution of exu protein in exuES21 mutants --- p.162 / Chapter 5.3.5 --- Rescue test of exuES2.1 trangenic flies --- p.165 / Chapter 5.4 --- Discussion --- p.168 / Chapter CHAPTER 6 --- General Discussion --- p.171 / References --- p.173 / Chapter Appendix I: --- List of reagents --- p.183 / Chapter Appendix II: --- Publication --- p.187

INTRODUÇÃO: A relevância da expressão MYCN em neuroblastomas sem amplificação, diferentemente do seu aumento quando amplificado, permanece controverso. Neste trabalho, avaliou-se a relação do nível de expressão do transcrito MYCN em neuroblastoma não amplificado com os fatores clínicos e biológicos de prognóstico. MÉTODOS: Neste estudo observacional realizado entre janeiro de 2000 e dezembro de 2004, foram aferidos os valores do nível de expressão MYCN em 29 amostras tumorais, pela técnica RQ-PCR, no Laboratório de Biologia Tumoral da Fundação Pró-Sangue de São Paulo. Seus resultados foram analisados em relação à idade ao diagnóstico, ao estadiamento tumoral, ao grupo de risco, à ocorrência de recaída tumoral e de óbito. RESULTADOS: Foram nove crianças com idade 1 ano, os valores da expressão do transcrito MYCN variaram de 0,041 e 27,569, mediana 3,193. O estadiamento foi: quatro estádio 1; três estádio 2; oito estádio 3 e 14 crianças estádio 4. Entre 20 crianças com classificação patológica, 11 foram favoráveis e nove desfavoráveis. Considerando a mediana dos valores expressos a estratificação em grupos de risco com aumento da expressão foram: cinco crianças baixo risco; quatro risco intermediário e cinco alto risco. Grupos de risco sem aumento da expressão foram: duas crianças baixo risco; quatro risco intermediário e nove alto risco. Vinte e oito crianças obtiveram remissão completa e entre elas 14 apresentaram doença progressiva, sendo que sete morreram. As variáveis clínicas e biológicas não apresentaram freqüências diferentes entre os grupos de risco sem e com aumento de expressão. Entre os grupo alto risco e não alto-risco as variáveis idade, recaída tumoral e óbito apresentaram resultado com significado estatístico quando não se considerou o valor da expressão e quando não houve o seu aumento. Entre os grupos alto risco e nãoalto risco com aumento da expressão apenas a idade apresentou resultado com significado estatístico. CONCLUSÃO: Em crianças com estádio clínico não avançado o nível de expressão parece exercer uma relevância clínica, sugerindo um efeito protetor quanto menor for o aumento da expressão MYCN. / INTRODUTION: MYCN expression value in non-amplified neuroblastosmas remains a controversial issue. In order to add contributions to this field, children with nonamplified neuroblastomas were studied regarding their expression and correlation with clinical and other biological factors. METHODS: Twenty nine tumor samples obtained from non-consecutive patients admitted from January, 2000 through December, 2004, had their MYCN transcript expression levels evaluated according to the RQ-PCR assay, at the Tumoral Biology of Laboratory of the \"Fundação Pró -Sangue Hemocentro de São Paulo\", and compared to the following other factor: age at onset; tumor stage; risk - group; tumoral relapse rate and death. RESULTS: nine under one-year-old children and 20 over one-year-old children, with MYCN transcription expression level between 0.041 and 27.569, mean 3.193. Four children were stage 1, three were stage 2, stage 3 in eight and stage 4 in 14 children. In 20 patients with pathological classifications, 11 were favorable and nine unfavorable histology. Children whose expression level was above the mean were stratified as follows according to risk groups: five low-risk; four intermediate-risk and five high-risk patients. The ones whose expression level was under the mean were two low-risk, four intermediate-risk end nine high-risk patients. Twenty eight children achieved complete remission, with 14 recurrences, with seven deaths. The only factor associated to highly expressed MYCN patients was tumoral state. CONCLUSION: In children with non-advanced-stage disease low levels of expression might be a relevant favorable prognostic factor.

Pre-mRNA molecules in humans contain mostly short internal exons flanked by long introns. To explain the removal of such introns, recognition of the exons instead of recognition of the introns has been proposed. This thesis studies this exon definition mechanism using a bottom-up approach. To reduce the complexity of the system under study, this exon definition mechanism was addressed using designer exons made up of prototype sequence modules of our own design (including an exonic splicing enhancer or silencer). Studies were performed in vitro with a set of DEs obtained from random combinations of the exonic splicing enhancer and the exonic splicing silencer modules. The results showed considerable variability both in terms of the composition and size of the DEs and in terms of their inclusion level. To understand how different DEs generated different inclusion levels, the problem was divided into understanding separately parameters varied between DEs. Subsequent studies focused on each of three parameters: size, ESE composition and ESS composition. The final objective was to be able to combine their effects to predict the inclusion levels obtained for the "random" DEs mentioned previously. To complement this experimental approach an equation was generated in two stages. First a general "framework" equation was obtained modeling a necessary exon definition complex that enabled commitment to inclusion. This equation used rates for the formation and dissociation of this complex without elaborating on the details for how those rates came about. In the second stage, however, formation and dissociation were modeled using novel but intuitive ideas and these models were combined into a final equation. This equation using the single-parameter perturbation data obtained previously performed well in predicting the inclusion levels of the "random" DEs. Additionally, both the final equation and the mechanisms proposed align well with results published by other groups. In order to make these results more accessible and to open more opportunities to extend them, an initial attempt is presented to identify the proteins involved in the functionality observed for each of the sequences used.

The ribosome is responsible for mRNA-templated protein translation in all living cells. The translational machinery (TM) has evolved to use 20 amino acids each esterified onto one of several tRNA bodies. While the active site of the ribosome, known as the peptidyl transferase center (PTC), is able to handle a remarkable amount of substrate diversity, many classes of unnatural amino acids are not compatible with the TM. For example, in the field of unnatural amino acid mutagenesis, the site-specific incorporation of biologically useful amino acids into proteins, such as fluorophores, has often proven to be unfeasible. This runs counter to the accepted notion that the ribosome is blind to the structure of the amino acid and is capable of accepting any amino acid as long as the mRNA codon: tRNA anticodon pairing is correct. Two studies by our group set out to test the hypothesis that the ribosome can indeed discriminate the structure of the amino acid. Using a fully purified E. coli translation system, the first study showed that natural amino acids misacylated onto fully modified but non-native tRNAs show small but reproducible effects on the steps of aminoacyl-tRNA (aa-tRNA) selection. The second study, in which I participated, utilized D-aa-tRNAs in the same E. coli translation system to study how amino acids of the inverted stereochemistry to those found in ribosomally-synthesized proteins affect translation elongation. We showed that these unnatural substrates serve as peptidyl acceptors but once translocated into the P-site of the ribosome, fail as peptidyl donors and stall translation elongation by inactivating the PTC. The motivation of my work has been to further characterize the effects of D-aa-tRNAs on translation elongation. To this end, I examined how the PTC is affected structurally and functionally by the presence of ribosomal substrates containing D-amino acids. Chapter one contains an introduction to this work. Chapter two describes chemical probing experiments that demonstrate that the presence of peptidyl-D-aminoacyl-tRNAs in the P-site of the ribosome allosterically modulates the secondary structure of ribosomal exit tunnel nucleotides A2058 and A2059. Chapter three describes how the reactivity of peptidyl-D-aminoacyl-tRNAs to form tripeptides is highly dependent on the identity of the amino acid it is reacting with; protein yields can be close to what is obtained with natural amino acids or almost completely abolished. Chapter four contains the methods used to do this research. From the observations presented here as well as from the work of other laboratories, a picture of the PTC emerges in which the pairing of the A- and P- site substrates is integral in either promoting or suppressing catalysis by the PTC. This work has implications for the field of unnatural amino acid mutagenesis, particularly for strategies to improve the incorporation of interesting unnatural amino acid by the ribosome. In addition, this work adds an important aspect to the growing body of knowledge of ribosome stalling at the PTC.

Ribosomes are universally conserved macromolecular machines found within all living cells that catalyze protein synthesis, one of nature’s most fundamental processes. Ribosomes synthesize proteins, which are polymeric chains of amino acids, by incorporating the amino acids one at a time via aminoacylated-transfer RNAs (aa-tRNAs), based on translation of the sequence of triplet- nucleotide codons presented by the messenger RNA (mRNA) template that is a direct readout of genomic DNA. Recent biochemical, structural, dynamic, and computational studies have uncovered large-scale conformational changes of the ribosome, its tRNA substrates, and the additional protein translation factors that play important roles in regulating protein synthesis, especially during the elongation phase of translation when the bulk of each protein is synthesized. How the ribosome, its translation elongation factors, tRNAs, and mRNA physically coordinate and regulate the movements of the tRNAs carrying amino acids into, through, and out of the ribosome remains one of the more fundamental questions in the mechanistic studies of protein synthesis. A complete understanding of the conformational dynamics of ribosomal complexes will improve our knowledge of how translation is regulated, including how ribosome-targeting antibiotics regulate translation elongation, and will provide crucial information for designing next-generation antibiotics. In this thesis I have investigated the conformational dynamics of the ribosome during the elongation phase of protein synthesis at the single-molecule level using single-molecule fluorescence resonance energy transfer (smFRET) microscopy experiments. Specifically, I have studied ribosomal dynamics during the elongation phase of translation in the presence of a tRNAPro in the context of an mRNA that has the propensity to shift out of the reading frame. My studies have revealed information about the mechanistic and regulatory functions of the posttranscriptional modifications of tRNAPro in a context in which the ribosomal complex has the propensity to undergo non-programmed +1-frameshifting, in which the tRNA-mRNA base pairing shifts one base toward the 3’ end of the mRNA, and if unchecked, leads to the synthesis of a polypeptide with a completely different sequence of amino acids. My data suggests that in this context, the mechanism underlying non-programmed +1-frameshifting involves the tRNA shifting out of frame prior to the tRNA being accommodated in the P site, i.e. either while the tRNA is in the A site, or more likely, during translocation of the tRNA from the A site to the P site, and not while the tRNA is already occupying the P site, as previously proposed.

Autophagy is an evolutionarily conserved degradative eukaryotic cell pathway that plays a role in multiple cellular processes. One important function is as a key component of the cellular immune response to invading microbes. Autophagy has been found to directly target and degrade multiple intracellular bacterial species. In this thesis, I identify and characterize two distinct regulatory mechanisms for this pathway involving the second messengers: diacylglycerol and cyclic adenosine monophosphate (cAMP). Salmonella enteric serovar Typhimurium (S. Typhimurium) is a Gram-negative bacterial species that has been shown to be intracellularly targeted for degradation by autophagy. While targeting of this species has been previously shown to involve ubiquitination, this pathway accounts for only half of targeted bacteria. Here I show that ubiquitin-independent autophagy of S. Typhimurium requires the lipid second messenger diacylglycerol. Diacylglycerol localization to the bacteria precedes autophagy and functions as a signal to recruit the delta isoform of protein kinase C (PKC) in order to promote the specific autophagy of tagged bacteria. Furthermore, I have found that the role of diacylglycerol and PKC delta is not limited to antibacterial autophagy but also functions in rapamycin-induced autophagy indicating a general role for these components in this process. Multiple bacterial species have been found to be targeted by autophagy and while some have developed strategies that allow them to avoid targeting, no bacterial factor has yet been identified that is able to inhibit the initiation of this process. Here I show that two bacterial species, Bacillus anthracis and Vibrio cholera inhibit autophagy through the elevation of intracellular cAMP and activation of protein kinase A. Using two different bacterial cAMP-elevating toxins, I show that multiple types of autophagy are inhibited in the presence of these toxins. This is indicative of a general inhibitory function for these toxins and identifies a novel bacterial defence strategy. This work characterizes both a novel regulatory signal for the induction of autophagy and identifies a novel bacterial tactic to inhibit this process. Together the data presented in this thesis provide novel insight into the regulation of autophagy and offer potential targets for modulation of this process.